BG Stock Cash Flow Statements

Bunge Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Bunge Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-03-31	2009-06-30	2009-03-31

operating activities
net income	389,000,000	629,000,000	659,000,000	374,000,000	383,000,000	225,000,000	696,000,000	232,000,000	649,000,000	369,000,000	917,000,000	569,000,000	267,000,000	522,000,000	-193,000,000	-71,000,000	-1,482,000,000	212,000,000	50,000,000	-58,000,000	-10,000,000	266,000,000	89,000,000	133,000,000	312,000,000	235,000,000	80,000,000	322,000,000	-176,000,000
adjustments to reconcile net income to cash from operating activities:
impairment charges	34,000,000			76,000,000								2,000,000	7,000,000	0	1,000,000	161,000,000	1,642,000,000	13,000,000	9,000,000	13,000,000
foreign exchange (gain) loss on net debt	23,000,000	-124,000,000	-50,000,000	-5,000,000	-90,000,000	110,000,000	-116,000,000		140,000,000	-108,000,000	-25,000,000	-80,000,000	-19,000,000	-21,000,000	-86,000,000					5,000,000
bad debt expense	4,000,000	5,000,000	-1,000,000	7,000,000	14,000,000	4,000,000	5,000,000	1,000,000	1,000,000	2,000,000	1,000,000	2,000,000	3,000,000	52,000,000	13,000,000	4,000,000	1,000,000	-3,000,000	7,000,000	36,000,000	-1,000,000	13,000,000	16,000,000	6,000,000			11,000,000	15,000,000	8,000,000
depreciation, depletion and amortization	109,000,000	106,000,000	102,000,000	103,000,000	101,000,000	102,000,000	102,000,000	107,000,000	105,000,000	106,000,000	106,000,000	112,000,000	106,000,000	104,000,000	113,000,000	120,000,000	134,000,000	155,000,000	139,000,000	159,000,000	199,000,000	144,000,000	120,000,000	151,000,000	143,000,000	104,000,000	102,000,000	105,000,000	95,000,000
share-based compensation expense	17,000,000	17,000,000	17,000,000	18,000,000	15,000,000	16,000,000	16,000,000	15,000,000	17,000,000	16,000,000	13,000,000	24,000,000	20,000,000	12,000,000	15,000,000	9,000,000	13,000,000	13,000,000	4,000,000	15,000,000
deferred income tax expense	48,000,000	56,000,000	11,000,000		-33,000,000	-5,000,000	-54,000,000		-180,000,000	-119,000,000	36,000,000
results from affiliates	-39,000,000
other	5,000,000	57,000,000	-5,000,000	-31,000,000	-35,000,000	25,000,000	2,000,000	-54,000,000	-49,000,000	-36,000,000	-20,000,000	-7,000,000	-43,000,000	61,000,000	44,000,000	22,000,000	-21,000,000	-25,000,000	12,000,000	-31,000,000			41,000,000				13,000,000	23,000,000	-26,000,000
changes in operating assets and liabilities, excluding the effects of acquisitions and dispositions:
trade accounts receivable	16,000,000	285,000,000	5,000,000	153,000,000	-18,000,000	51,000,000	-392,000,000	255,000,000	-1,000,000	-167,000,000	-617,000,000	-18,000,000	-138,000,000	-5,000,000	-94,000,000	57,000,000	-208,000,000	22,000,000	-128,000,000	49,000,000							-380,000,000	-13,000,000	374,000,000
inventories	1,128,000,000	239,000,000	-434,000,000		2,112,000,000	9,000,000	-2,350,000,000		232,000,000	445,000,000	-1,448,000,000	-619,000,000	-371,000,000	-557,000,000	-751,000,000	559,000,000	-60,000,000	99,000,000	-94,000,000	1,358,000,000						40,000,000	632,000,000	-1,131,000,000	603,000,000
secured advances to suppliers	-217,000,000	-26,000,000	15,000,000			98,000,000	-52,000,000	-6,000,000	-67,000,000	20,000,000	5,000,000	134,000,000	-78,000,000	-113,000,000	-105,000,000	202,000,000	-182,000,000	-89,000,000	-31,000,000	236,000,000							31,000,000	213,000,000	44,000,000
trade accounts payable and accrued liabilities	-85,000,000	-1,407,000,000	802,000,000	-192,000,000	-684,000,000	-224,000,000	1,167,000,000										205,000,000	-751,000,000	248,000,000		-4,000,000	-467,000,000	653,000,000
advances on sales	-7,000,000	-101,000,000	-119,000,000	256,000,000	-27,000,000	-24,000,000	-30,000,000	161,000,000	21,000,000	-81,000,000	-69,000,000	108,000,000	-35,000,000	-3,000,000	-81,000,000	187,000,000	-3,000,000	-72,000,000	-97,000,000	179,000,000				-73,000,000	55,000,000	89,000,000	65,000,000	37,000,000	-16,000,000
net unrealized (gains) losses on derivative contracts	15,000,000	162,000,000	-424,000,000		-297,000,000	-372,000,000	213,000,000		-80,000,000	539,000,000	100,000,000		170,000,000	-586,000,000	589,000,000
margin deposits	-89,000,000	-163,000,000	141,000,000	-187,000,000	31,000,000	302,000,000	-388,000,000	-28,000,000	-111,000,000	109,000,000	282,000,000	-142,000,000	-270,000,000	114,000,000	-204,000,000	-82,000,000	24,000,000	19,000,000	102,000,000	160,000,000				170,000,000	60,000,000	330,000,000	166,000,000	-296,000,000	17,000,000
recoverable and income taxes	68,000,000	-215,000,000	128,000,000	107,000,000
marketable securities	-53,000,000	23,000,000	13,000,000	-16,000,000	56,000,000	42,000,000	243,000,000	13,000,000	-90,000,000	-69,000,000	64,000,000	-52,000,000	36,000,000	-59,000,000	121,000,000	83,000,000	-37,000,000	-236,000,000	-36,000,000	-40,000,000
beneficial interest in securitized trade receivables				-1,652,000,000	-1,845,000,000	-1,806,000,000	-1,637,000,000	-1,755,000,000	-1,500,000,000	-1,094,000,000	-1,027,000,000	-837,000,000	-417,000,000	-331,000,000	-430,000,000	-522,000,000	-246,000,000	-277,000,000	-244,000,000	-470,000,000
cash from operating activities	1,388,000,000	-459,000,000	931,000,000	-518,000,000	-574,000,000	-1,801,000,000	-2,656,000,000	-1,252,000,000	-206,000,000	-449,000,000	-987,000,000	-1,408,000,000	-626,000,000	-1,063,000,000	-439,000,000	505,000,000	-230,000,000	-681,000,000	-402,000,000	2,021,000,000				1,099,000,000	-470,000,000	734,000,000	760,000,000	-1,391,000,000	-363,000,000
investing activities
payments made for capital expenditures	-264,000,000	-368,000,000	-173,000,000	-202,000,000	-141,000,000	-106,000,000	-106,000,000	-160,000,000	-106,000,000	-80,000,000	-53,000,000	-135,000,000	-103,000,000	-72,000,000	-55,000,000	-146,000,000	-113,000,000	-146,000,000	-119,000,000	-175,000,000							-287,000,000	-234,000,000	-112,000,000
proceeds from investments	7,000,000	13,000,000	1,000,000	109,000,000	130,000,000	69,000,000	18,000,000	0	145,000,000			35,000,000	32,000,000	158,000,000	80,000,000	76,000,000	160,000,000	176,000,000	37,000,000	18,000,000			18,000,000	19,000,000	59,000,000	16,000,000	52,000,000	30,000,000	30,000,000
payments for investments	-6,000,000	-16,000,000	-4,000,000	-96,000,000	-108,000,000	-63,000,000	-54,000,000	-91,000,000	-64,000,000	-65,000,000	-88,000,000	-44,000,000	-67,000,000	-122,000,000	-104,000,000	-51,000,000	-65,000,000	-84,000,000	-193,000,000	-21,000,000
settlements of net investment hedges	-9,000,000			18,000,000	-10,000,000	-142,000,000	-1,000,000		-4,000,000	-16,000,000	-9,000,000		1,000,000
proceeds from beneficial interest in securitized trade receivables	6,000,000	18,000,000	61,000,000		1,865,000,000	1,698,000,000	1,613,000,000		1,383,000,000	1,080,000,000	969,000,000		416,000,000	325,000,000	423,000,000		253,000,000	272,000,000	275,000,000
proceeds from disposals of businesses and property, plant and equipment	3,000,000	3,000,000	159,000,000		495,000,000				301,000,000	14,000,000	331,000,000
payments for investments in affiliates	-6,000,000	-36,000,000	-94,000,000	0	-1,000,000			0	-4,000,000	-7,000,000	-35,000,000	0	-12,000,000	-1,000,000	-1,000,000	-30,000,000	-3,000,000	-2,000,000	-4,000,000	-1,000,000
cash from investing activities	-262,000,000	-429,000,000	45,000,000	1,386,000,000	2,246,000,000	1,419,000,000	1,448,000,000	1,551,000,000	1,673,000,000	774,000,000	1,115,000,000	833,000,000	252,000,000	334,000,000	394,000,000	1,079,000,000	239,000,000	226,000,000	-41,000,000	186,000,000							-381,000,000	-182,000,000	-165,000,000
financing activities
net change in short-term debt with maturities of three months or less	187,000,000	-33,000,000	7,000,000
proceeds from short-term debt with maturities greater than three months	391,000,000	303,000,000	154,000,000
repayments of short-term debt with maturities greater than three months	-311,000,000	-124,000,000	-158,000,000
proceeds from long-term debt	-3,000,000	-22,000,000	1,000,000,000	249,000,000	-2,000,000	20,000,000	30,000,000	3,000,000	0	983,000,000	15,000,000	20,000,000	619,000,000	1,684,000,000	78,000,000	478,000,000	1,504,000,000	2,284,000,000	978,000,000	1,541,000,000	6,430,000,000	1,273,000,000	1,488,000,000	832,000,000	646,000,000	731,000,000	129,000,000	2,759,000,000	98,000,000
repayments of long-term debt	0	-878,000,000	-1,000,000	0	-401,000,000	-27,000,000	-601,000,000				-15,000,000	-529,000,000	-18,000,000	-1,486,000,000	-81,000,000	-905,000,000	-1,297,000,000	-2,120,000,000	-1,376,000,000	-2,213,000,000
proceeds from the exercise of options for common shares	3,000,000	1,000,000	3,000,000	62,000,000	-14,000,000	12,000,000	32,000,000	44,000,000	0	28,000,000	44,000,000	7,000,000	0	0	2,000,000	9,000,000	1,000,000	2,000,000	5,000,000	0
repurchases of common shares				0				0				0	0
dividends paid to common and preference shareholders	-99,000,000	-94,000,000	-94,000,000		-94,000,000	-80,000,000	-82,000,000		-82,000,000	-79,000,000	-79,000,000		-78,000,000	-80,000,000	-79,000,000		-79,000,000	-79,000,000	-79,000,000
capital contributions from (return of capital to) noncontrolling interest	7,000,000
sale of noncontrolling interest				21,000,000	0
acquisition of redeemable noncontrolling interest and noncontrolling interest				0
cash from financing activities	-305,000,000	-809,000,000	901,000,000	-667,000,000	-1,547,000,000	737,000,000	708,000,000	-466,000,000	-936,000,000	60,000,000	-290,000,000	634,000,000	403,000,000	810,000,000	-84,000,000	-1,567,000,000	51,000,000	232,000,000	513,000,000	-2,078,000,000	45,000,000	1,631,000,000	1,033,000,000				-321,000,000	1,501,000,000	30,000,000
effect of exchange rate changes on cash and cash equivalents, restricted cash, and cash held for sale	12,000,000	0	28,000,000	-46,000,000
net increase in cash and cash equivalents, restricted cash, and cash held for sale	833,000,000	-1,697,000,000	1,905,000,000	155,000,000
cash and cash equivalents, restricted cash, and cash held for sale - beginning of period	0	0	1,152,000,000	0
cash and cash equivalents, restricted cash, and cash held for sale - end of period	833,000,000	-1,697,000,000	3,057,000,000	155,000,000
(gain) loss on sale of investments and property, plant and equipment		0	-3,000,000				-1,000,000		-176,000,000	-1,000,000	-239,000,000
deferred income tax (benefit) expense
gain on sale of investments and property, plant and equipment
changes in operating assets and liabilities, excluding the effects of acquisitions:
inventories, including net unrealized mark-to-market gains
net unrealized (gain) loss on derivative contracts
proceeds from interest in securitized trade receivables
payments for beneficial interest in securitized trade receivables								0	0
proceeds from divestiture of business and disposal of property, plant and equipment
proceeds from short-term debt				7,332,000,000	8,390,000,000	13,130,000,000	6,712,000,000	5,443,000,000	4,171,000,000	8,318,000,000	11,668,000,000	9,141,000,000
repayments of short-term debt				-8,142,000,000	-9,132,000,000	-12,855,000,000	-5,411,000,000	-5,896,000,000	-4,844,000,000	-9,197,000,000	-11,757,000,000	-7,909,000,000
dividends paid to preference shareholders																											-19,000,000	-20,000,000	-19,000,000
dividends paid to common shareholders																											-30,000,000	-23,000,000	-23,000,000
dividends paid to noncontrolling interests
proceeds from sale of investments in affiliates								0
dividends paid to noncontrolling interest																												0	-8,000,000
acquisition of noncontrolling interest								0	0	0	-147,000,000
effect of exchange rate changes on cash and cash equivalents and restricted cash						62,000,000	1,000,000		21,000,000	-133,000,000	33,000,000		0	3,000,000	2,000,000		-15,000,000	2,000,000	6,000,000
net increase in cash and cash equivalents and restricted cash						417,000,000	-499,000,000		552,000,000	252,000,000	-129,000,000		29,000,000	84,000,000	-127,000,000		45,000,000	-221,000,000	76,000,000
cash and cash equivalents and restricted cash - beginning of period						0	905,000,000		0	0	381,000,000		0	0	322,000,000		0	0	393,000,000
cash and cash equivalents and restricted cash - end of period						417,000,000	406,000,000		552,000,000	252,000,000	252,000,000		29,000,000	84,000,000	195,000,000		45,000,000	-221,000,000	469,000,000
foreign exchange gain on net debt
trade accounts payable								326,000,000	531,000,000	-397,000,000	1,134,000,000	-163,000,000	185,000,000	-647,000,000	722,000,000											355,000,000	434,000,000	44,000,000	-1,155,000,000
net unrealized gain on derivative contracts																				122,000,000
accrued liabilities																											145,000,000	67,000,000	-136,000,000
settlement of net investment hedges																		12,000,000	-51,000,000	-58,000,000
proceeds from divestiture of businesses and disposal of property, plant and equipment
effect of exchange rate changes on cash and cash equivalents, and restricted cash																				-7,000,000
net increase in cash and cash equivalents, and restricted cash																				122,000,000
cash and cash equivalents, and restricted cash - beginning of period																				0
cash and cash equivalents, and restricted cash - end of period																				122,000,000
acquisitions of businesses																				-13,000,000							-133,000,000	-15,000,000	-4,000,000
capital contributions (return of capital) from noncontrolling interests
deferred income tax loss													1,000,000
net change in short-term debt with maturities of 90 days or less														773,000,000	-54,000,000	-976,000,000	-40,000,000	5,000,000	1,193,000,000	-1,204,000,000	-128,000,000	1,549,000,000	69,000,000				36,000,000	402,000,000	-38,000,000
proceeds from short-term debt with maturities greater than 90 days														24,000,000	66,000,000	35,000,000	65,000,000	35,000,000	9,000,000	-22,000,000	106,000,000	175,000,000	194,000,000	232,000,000	363,000,000	76,000,000	170,000,000	277,000,000	507,000,000
repayments of short-term debt with maturities greater than 90 days														3,000,000	-7,000,000	-112,000,000	-94,000,000	110,000,000	-214,000,000	-87,000,000							-514,000,000	-297,000,000	-328,000,000
deferred income tax benefit															-68,000,000
(gain) loss, net on disposal of affiliate investments and subsidiaries
(gain) loss on sale of investments and property, plant, and equipment
foreign exchange loss on net debt																	114,000,000	1,000,000	37,000,000
deferred income tax																	-22,000,000	6,000,000	-3,000,000
net unrealized gains and losses on derivative contracts																	-106,000,000	156,000,000	-370,000,000
(gain) loss on disposition of equity interests/subsidiaries
proceeds from disposals of property, plant and equipment
dividends paid
gain on sale of investments in affiliates
gain on acquisition of controlling interest
foreign exchange gain on debt																												-479,000,000	120,000,000
stock-based compensation expense																						12,000,000	19,000,000	14,000,000	11,000,000	15,000,000	6,000,000	6,000,000	10,000,000
deferred income taxes																											-39,000,000	29,000,000	-133,000,000
prepayments and advances to suppliers
net unrealized gain/loss on derivative contracts
proceeds from sale of common shares																						2,000,000	8,000,000	3,000,000	4,000,000	12,000,000	1,000,000
effect of exchange rate changes on cash and cash equivalents																							5,000,000		-2,000,000	12,000,000		63,000,000	-8,000,000
net increase in cash and cash equivalents																							415,000,000			234,000,000	58,000,000
cash and cash equivalents, beginning of period																						0	835,000,000	0	0	578,000,000	553,000,000	0	1,004,000,000
cash and cash equivalents, end of period																						-783,000,000	1,250,000,000	585,000,000	-342,000,000	812,000,000	473,000,000	-9,000,000	498,000,000
investments in affiliates
gain on sale of fertilizer nutrients assets
impairment of assets																											12,000,000
recoverable taxes provision																										1,000,000	4,000,000	22,000,000	15,000,000
gain on sale of property, plant and equipment
equity in earnings of affiliates																												-5,000,000	-6,000,000
prepaid commodity purchase contracts																											-25,000,000	-177,000,000	-34,000,000
other—net																											-273,000,000	-98,000,000	-258,000,000
proceeds from sales of fertilizer nutrients assets
cash disposed in sale of fertilizer nutrients assets
related party loans																								3,000,000			-15,000,000	33,000,000	-52,000,000
proceeds from disposal of property, plant and equipment																								20,000,000	46,000,000	1,000,000	2,000,000	4,000,000	1,000,000
repurchase of common shares
capital contributions from noncontrolling interest																								11,000,000
financing related fees
unrealized net gain/loss on derivative contracts																									45,000,000	84,000,000	-304,000,000
capital contribution from noncontrolling interest in less than wholly-owned subsidiaries																										42,000,000
cash related to assets held for sale																											-138,000,000
foreign exchange loss on debt																											93,000,000
change in restricted cash																												0	-28,000,000
repayment of long-term debt																											-107,000,000	-1,621,000,000	-133,000,000
unrealized net gain on derivative contracts
unrealized net (gain) loss on derivative contracts																													265,000,000
net decrease in cash and cash equivalents																													-506,000,000

We provide you with 20 years of cash flow statements for Bunge stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bunge stock. Explore the full financial landscape of Bunge stock with our expertly curated income statements.

The information provided in this report about Bunge stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.